Try our Advanced Search for more refined results

Ranbaxy Eyes Merck's Generics Unit

By Erin Marie Daly (January 10, 2007, 12:00 AM EST) -- India's Ranbaxy Laboratories Ltd. may become the latest big generic maker to jump on the buyout bandwagon, with the company revealing on Tuesday that it is interested in bidding for the generic drug unit of Germany's Merck KGaA....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!